These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Helsinki Heart Study. New perspectives in the prevention of coronary heart disease. Huttunen JK, Frick MH, Heinonen OP, Heinsalmi P, Manninen V, Mänttäri M, Romo M. Drugs; 1988 Dec; 36 Suppl 3():32-6. PubMed ID: 3076118 [Abstract] [Full Text] [Related]
12. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R, La Belle P, Zupkis R, Ronca P. Am J Cardiol; 1990 Sep 18; 66(8):16B-21B. PubMed ID: 2206032 [Abstract] [Full Text] [Related]
17. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins. Sarlund H, Laakso M, Voutilainen E, Penttilä I, Pyörälä K. Atherosclerosis; 1991 Jan 18; 86(1):17-29. PubMed ID: 2064632 [Abstract] [Full Text] [Related]
18. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Diabetes; 1997 Aug 18; 46(8):1354-9. PubMed ID: 9231662 [Abstract] [Full Text] [Related]
19. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA. Mayo Clin Proc; 1994 May 18; 69(5):430-5. PubMed ID: 8170193 [Abstract] [Full Text] [Related]